HumanFirst
San Francisco
About HumanFirst
HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA). At HumanFirst, we offer a precision measures platform - the world’s largest AI-powered SaaS platform trusted to improve human outcomes. We provide insights, intelligence, and accuracy with validated evidence data to precisely guide and accelerate human-centric drug development. Twenty-two of the 25 largest pharmaceutical companies in the world have used the HumanFirst platform to evaluate and enable the deployment of digital health technologies (DHTs).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $1K – $10K
- Total funding: $14.9M
- Funding stage: M&A
- Last round: Series A (May 2021)
- Website: gohumanfirst.com
- Phone: [email protected]
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/humanfirst-104152 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.